Why Cell‐Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection

Rosenheck JP, Keller BC, Fehringer G, et al. Curr Pulmonol Rep. 2022

Letter to the Editors: Performance of Donor-derived Cell-free DNA Assays in Kidney Transplant Patients

Altug Y, Demko ZP, Ryan A. Letter to the Editors - Transplantation. 2020

Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection

Bunnapradist S, Homkrailas P, Ahmed E, et al. J Am Soc Nephrol 2021

Single center experience comparing two clinically available donor derived cell free DNA tests and review of literature

Lum EL, Nieves-Borrero K, Homkrailas P, et al. Transplantation Reports. 2021

Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management

Qazi Y, Patel A, Fajardo M, et al. Transplant Proc. 2021

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplanta

Ventura-Aguiar P, Ramirez-Bajo MJ, Rovira J, et al. Transplantation. 2022

The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies

Halloran PF, Reeve J, Madill-Thomsen KS, et al. J Am Soc Nephrol.

Real-world Clinical Experience Implementing Donor-derived Cell- free DNA for Detection of Acute Lung Allograft Dysfunction after Lung Trans

Girgis R, Lawson C, Bhorade S, et al. Mar Pulmonology and Respiratory Medicine (2023)

Prospera Patient Discussion Guide

Compassionate Care Application - Spanish

ASN 2023 Natera Presence Flyer